Research LetterLongevity of model 3501 subcutaneous implantable cardioverter-defibrillator leads in clinical practice
Graphical abstract
Section snippets
Acknowledgments
We thank Engineer Stefano Accinelli (Boston Scientific technical service) for the technical support.
References (5)
- et al.
Recommendations from the Heart Rhythm Society Task Force on Lead Performance Policies and Guidelines: developed in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA)
Heart Rhythm
(2009) - et al.
Long-term clinical outcomes of subcutaneous versus transvenous implantable defibrillator therapy
J Am Coll Cardiol
(2016)
There are more references available in the full text version of this article.
Cited by (3)
Funding Sources: The authors have no funding sources to disclose.
Disclosures: This was an independent study. Dr Francia received speaker’s fees and educational grants from Boston Scientific and research grants from Abbott. The rest of the authors report no conflicts of interest.
- 1
Co-first author.
© 2022 Heart Rhythm Society. All rights reserved.